Medical imaging serves as an indispensable tool in advancing clinical research across various medical disciplines. The integration of imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET), enhances our ability to visualize and understand complex physiological processes, aiding in the diagnosis, treatment, and monitoring of diseases. In clinical research, medical imaging plays a pivotal role in assessing treatment efficacy, tracking disease progression, and providing valuable insights into the underlying mechanisms of various medical conditions. Researchers leverage imaging modalities to quantify biological changes, analyze response patterns, and refine therapeutic interventions.
The application of medical imaging in clinical trials enables non-invasive and quantitative assessments, contributing to more objective and reproducible research outcomes. It facilitates the identification of biomarkers, supports patient stratification, and enhances the overall precision of clinical investigations. Collaboration between radiologists, clinicians, and researchers is essential for the successful integration of medical imaging into clinical research protocols. Ethical considerations, patient safety, and data accuracy are paramount in the utilization of imaging technologies, aligning with regulatory standards and ensuring the reliability of research findings.
As technology advances, medical imaging continues to evolve, offering new possibilities for innovative research methodologies and contributing to the development of personalized and precision medicine. The intersection of medical imaging and clinical research remains a dynamic frontier, fostering continuous advancements in healthcare knowledge and patient care.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia